BBR In the News

A sampling of what the media is saying about the Bioscience Business Roundtable events:

"...Most said Texas has the medical facilities and the money to compete globally. What is missing, they said during a conference that featured Gov. Rick Perry as a keynote speaker, is an abundance of entrepreneurs and executives. 'More investments mean more jobs and innovations that improve human life, and that is really what this has all been about,' Perry said." (Fort Worth Star-Telegram, February 18, 2009)

"...The life sciences already have a strong footprint in Delaware, thanks in part to the presence of industry giants such as chemical and biotech firm DuPont Co., drug maker AstraZeneca and Agilent. A study earlier this year by the University of Delaware's Center for Applied Demography & Survey Research found that the biopharmaceutical and related sectors employed nearly 12,000 people in Delaware in 2008. Several speakers touted Delaware's advantages in the field of life sciences, including its strong sense of community, easy access to government officials and high concentration of Ph.D.s. 'We have a lot to build on,' Gov. Jack Markell said in the event's keynote speech." (The Wilmington News Journal, August 13, 2009)

"...With the cost to get a product to market being about $1.3 billion, and just two in 10 medicines earning more than the average cost of developing a new medicine, Lori Reilly, vice-president of Pharmaceutical Research and Manufacturers of America, said that without proper funding, innovation might be taken to other countries such as India, China, Korea and Singapore." (The Mercury News, August 28, 2009)

"...''The bioscience and biopharmaceutical industry in the state is in a growing mode despite the economic downturn,' said Nathan Tinker, executive director of the New York Biotechnology Association. 'The biopharmaceutical industry has a major role to play' in boosting the state's economy.

Biotechnology 'is truly one of our most important academic and industry and research clusters' in the Capital Region, said F. Michael Tucker, president and CEO of the Albany-based Center for Economic Growth." (Times Union, January 31, 2009)

"...More than 275 members of the bioscience, economic-development, academic and political communities were on hand at the Denver Athletic Club to hear panel discussions about the state's bioscience industry and strategies on how to strengthen it." (Denver Post, August 28, 2007)

"...The commissioner of the U.S. Food and Drug Administration told a Biz/Bio conference of about 300 biotech and government leaders this week in Annapolis that 'what you are doing today in Maryland is very important to the future of this country.'" (Maryland Business Gazette, February 22, 2008)

"...Promoting the industry, the panelists outlined organizations that largely promote the industry in their states, as well as advocate for policy in state legislatures." (The Oklahoman, April 30, 2008)

"...Those attending the forum also heard about how research conducted at both Yale University and the University of Connecticut is spawning new companies and providing revenue for those academic institutions." (Hartford Business Journal, January 23, 2006)

Take Action
Tell Congress to protect innovation and jobs in the bioscience community.
The Bioscience Brief
Subscribe to our newsletter for important information from the Bioscience Business Roundtable.